Kenneth R Trammell

Insider

First SEC filing: June 6, 2025 · Latest: June 6, 2025

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.

Insider at

UTI selling Nov. 27, 2024

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 20 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

20 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
March 5, 2026	UTI	A	3,565	—	—	136,083 Direct	+2.69%	Acquired	(price as of 2026-08-21)
June 5, 2025	UTI	A	714	—	—	132,518 Direct	+0.54%	Acquired	(price as of 2026-08-21)
Feb. 27, 2025	UTI	A	3,599	—	—	131,804 Direct	+2.81%	Acquired	(price as of 2026-08-21)
Nov. 27, 2024	UTI	M	30,000	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-21)
Nov. 27, 2024	UTI	S	30,000	$25.92	$777,600	128,205 Direct	-18.96%	Disposed	-10.3% (price as of 2026-08-21)
Nov. 27, 2024	UTI	M	30,000	$3.14	$94,200	158,205 Direct	+23.40%	Acquired	640.1% (price as of 2026-08-21)
Feb. 28, 2024	UTI	A	6,789	—	—	128,205 Direct	+5.59%	Acquired	(price as of 2026-08-21)
Feb. 22, 2023	UTI	A	9,895	—	—	121,416 Direct	+8.87%	Acquired	(price as of 2026-08-21)
Feb. 24, 2022	UTI	A	8,772	—	—	111,521 Direct	+8.54%	Acquired	(price as of 2026-08-21)
Feb. 24, 2021	UTI	A	11,905	$6.30	$75,002	102,749 Direct	+13.10%	Acquired	268.9% (price as of 2026-08-21)
Feb. 27, 2020	UTI	A	10,739	$7.45	$80,006	90,844 Direct	+13.41%	Acquired	211.9% (price as of 2026-08-21)
Feb. 27, 2019	UTI	A	14,286	—	—	80,105 Direct	+21.70%	Acquired	(price as of 2026-08-21)
Dec. 5, 2018	UTI	A	30,000	—	—	30,000 Direct	—	Acquired	(price as of 2026-08-21)
March 6, 2018	UTI	A	18,797	—	—	65,819 Direct	+39.97%	Acquired	(price as of 2026-08-21)
March 1, 2017	UTI	A	14,286	—	—	47,022 Direct	+43.64%	Acquired	(price as of 2026-08-21)
March 2, 2016	UTI	A	11,656	—	—	32,736 Direct	+55.29%	Acquired	(price as of 2026-08-21)
Feb. 18, 2015	UTI	A	5,453	—	—	21,080 Direct	+34.89%	Acquired	(price as of 2026-08-21)
Feb. 19, 2014	UTI	A	3,892	—	—	15,627 Direct	+33.17%	Acquired	(price as of 2026-08-21)
Feb. 20, 2013	UTI	A	4,181	—	—	11,735 Direct	+55.35%	Acquired	(price as of 2026-08-21)
Feb. 22, 2012	UTI	A	3,682	—	—	7,554 Direct	+95.09%	Acquired	(price as of 2026-08-21)
June 28, 2011	UTI	A	3,872	—	—	3,872 Direct	—	Acquired	(price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Nov. 27, 2024	UTI	Director Stock Option (Right to Buy)	Common Stock (30,000)	$3.14	Dec. 5, 2025	30,000	Disposed
Dec. 5, 2018	UTI	Director Stock Option (Right To Buy)	Common Stock (30,000)	$3.14	Dec. 5, 2025	30,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).